Exelixis, Inc. (NASDAQ:EXEL) on Mar. 25 announced that the Independent Data Monitoring Committee (IDMC) notified the company today that a planned interim analysis of the COMET-1 phase 3 pivotal trial has been completed, and that the IDMC recommended the trial proceed to its final analysis. Exelixis, Inc. (NASDAQ:EXEL) shares after opening at $3.90 moved to $3.91 on last trade day and at the end of the day closed at $3.38. Company price to sales ratio in past twelve months was calculated as 19.91 and price to cash ratio as 2.45. Exelixis, Inc. (NASDAQ:EXEL) showed a negative weekly performance of -46.26%.
AVEO Pharmaceuticals, Inc (NASDAQ:AVEO) was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since March 10, as the stock is down over 7%. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares fell -3.21% in last trading session and ended the day on $1.51. AVEO return on equity ratio is recorded as -105.50% and its return on assets is -58.80%. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) yearly performance is -79.46%.
Shares of Onconova Therapeutics (NASDAQ:ONTX) were the recipient of a large decrease in short interest in the month of January. As of February 28th, there was short interest totalling 1,272,556 shares, a decrease of 24.2% from the February 14th total of 1,679,370 shares, American Banking & Market News reports. Onconova Therapeutics Inc (NASDAQ:ONTX) shares moved down -5.12% in last trading session and was closed at $6.30 while trading in range of $6.05 – $6.70 – Onconova Therapeutics Inc (NASDAQ:ONTX) year to date (YTD) performance is -45.12%.
BioTime, Inc. (NYSEMKT:BTX) announced the results of its capital raising activities since October 1, 2013 through its $25 million Controlled Equity Offering facility, and through sales of BioTime common shares by certain of its subsidiaries, in “at-the-market” transactions through Cantor Fitzgerald & Co., as sales agent. BioTime, Inc. (NYSEMKT:BTX) weekly performance is -11.65%. On last trading day company shares ended up $3.11. BioTime, Inc. (NYSEMKT:BTX) distance from 50-day simple moving average (SMA50) is -14.58%.